Hour in Review — 2026-08-27 06:00 UTC14 sources
Global markets are navigating monetary divergence and energy vulnerability, with investors closely watching central banking signals as gold edges higher near $4,6001 and the U.S. dollar holds gains ahead of Federal Reserve Chair Kevin Warsh's Jackson Hole address1,2, while the Bank of Korea delivered another interest rate hike and lifted its economic growth and core inflation forecasts, boosting the South Korean won2,3. In commodity markets, Europe faces heightened winter energy risks with natural gas storage at historically low levels and disrupted Middle East LNG flows threatening to push prices above 100 euros4. Across technology, Chinese artificial intelligence developers continue an aggressive expansion drive: Hangzhou-based DeepSeek is seeking funding to support research and computing infrastructure at a $74 billion valuation5, MiniMax saw its shares climb following a 283% surge in first-half revenue and widening gross margins6, and Zhipu AI gained after confirming it developed the Ox Alpha model7, while Baidu shares surged on plans to convert its Hong Kong listing status to primary8. However, supply-chain and regulatory friction persists, highlighted by a U.S. probe into Apex Logistics over suspected smuggling of Nvidia chips9. In consumer and industrial corporate developments, demand patterns are displaying sharp bifurcation: Pernod Ricard warned that subdued drinking trends will constrain revenue after organic sales fell 14% in the U.S. and 19% in China10, even as non-tech consumer stocks like Cheesecake Factory, Victoria's Secret, Cracker Barrel, CarMax, and Airbnb logged year-to-date advances between 38% and 130%11, and Qantas shares advanced 4% on annual earnings and new business-class seating supported by robust premium travel demand12. Dealmaking and healthcare also saw notable milestones, with Boliden agreeing to buy a 64.68% stake in Nexa Resources for $1.31 billion13 and China’s drug regulator formally accepting Novo Nordisk’s regulatory filing for oral Wegovy14.
Sources